Benzonatate Capsule
Product Images NDC 51224-001

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Benzonatate (NDC 51224-001). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Tagi Pharma, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Benzonatate 01

Label for Benzonatate Capsules USP 100 mg by TAGI Pharma, Inc. The label indicates each soft gelatin capsule contains 100 mg of benzonatate. It includes storage instructions, dosage directions to see the package insert, and patient cautions not to break or chew capsules. Manufactured by CSPC-NBP Pharmaceutical Co., LTD. The label displays a quantity of 100 capsules and features barcodes and manufacturer logos.*

FDA Label Image

Benzonatate 02

Label for Benzonatate Capsules USP 200 mg by TAGI Pharma, Inc. The label states the product contains 100 capsules and includes storage instructions, manufacturer and distributor information, and a barcode. The text warns to swallow capsules whole and not to break or crush them.*

FDA Label Image

Benzonatate_chem_structure.jpg (Structure)

Chemical structure diagram of Benzonatate, displaying its molecular formula C30H53NO11 with a detailed depiction of its aromatic ring and associated side chains.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.